1369P EGFR T790M ctDNA abundance and TP53 co-mutation by next generation sequencing predicted clinical outcomes of osimertinib in non-small cell lung cancer patients from a real-world study
2016 ◽
2017 ◽
2017 ◽
Vol 9
(S13)
◽
pp. S1383-S1390
◽
2016 ◽
Vol 11
(10)
◽
pp. S168-S169
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. e20630-e20630